Annual CFO
-$10.84 M
+$6.19 M+36.34%
31 December 2023
Summary:
ProMIS Neurosciences annual cash flow from operations is currently -$10.84 million, with the most recent change of +$6.19 million (+36.34%) on 31 December 2023. During the last 3 years, it has fallen by -$7.43 million (-217.53%). PMN annual CFO is now -856.40% below its all-time high of -$1.13 million, reached on 01 December 2015.PMN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$6.67 M
-$5.17 M-343.41%
30 September 2024
Summary:
ProMIS Neurosciences quarterly cash flow from operations is currently -$6.67 million, with the most recent change of -$5.17 million (-343.41%) on 30 September 2024. Over the past year, it has dropped by -$4.29 million (-180.71%). PMN quarterly CFO is now -9589.47% below its all-time high of $70.30 thousand, reached on 01 September 2010.PMN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$22.23 M
-$4.29 M-23.95%
30 September 2024
Summary:
ProMIS Neurosciences TTM cash flow from operations is currently -$22.23 million, with the most recent change of -$4.29 million (-23.95%) on 30 September 2024. Over the past year, it has dropped by -$10.59 million (-90.95%). PMN TTM CFO is now -14560.42% below its all-time high of -$151.60 thousand, reached on 01 June 2005.PMN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.3% | -180.7% | -91.0% |
| 3 y3 years | -217.5% | -120.2% | -263.2% |
| 5 y5 years | -70.9% | -493.8% | -376.7% |
PMN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -217.5% | +36.3% | -343.4% | +35.2% | -263.2% | at low |
| 5 y | 5 years | -217.5% | +36.3% | -941.5% | +35.2% | -591.5% | at low |
| alltime | all time | -856.4% | +36.3% | -9589.5% | +35.2% | <-9999.0% | at low |
ProMIS Neurosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.67 M(+343.4%) | -$22.23 M(+24.0%) |
| June 2024 | - | -$1.50 M(-85.4%) | -$17.93 M(-3.5%) |
| Mar 2024 | - | -$10.29 M(+173.8%) | -$18.57 M(+71.3%) |
| Dec 2023 | -$10.84 M(-36.3%) | -$3.76 M(+58.1%) | -$10.84 M(-6.8%) |
| Sept 2023 | - | -$2.38 M(+10.7%) | -$11.64 M(-16.3%) |
| June 2023 | - | -$2.15 M(-16.2%) | -$13.90 M(-14.4%) |
| Mar 2023 | - | -$2.56 M(-43.7%) | -$16.23 M(-4.7%) |
| Dec 2022 | -$17.03 M(+83.1%) | -$4.55 M(-1.8%) | -$17.03 M(+3.1%) |
| Sept 2022 | - | -$4.64 M(+3.5%) | -$16.53 M(+10.8%) |
| June 2022 | - | -$4.48 M(+33.0%) | -$14.92 M(+25.4%) |
| Mar 2022 | - | -$3.37 M(-16.8%) | -$11.89 M(+27.8%) |
| Dec 2021 | -$9.31 M(+172.5%) | -$4.05 M(+33.5%) | -$9.31 M(+52.1%) |
| Sept 2021 | - | -$3.03 M(+108.9%) | -$6.12 M(+63.8%) |
| June 2021 | - | -$1.45 M(+86.6%) | -$3.74 M(+16.2%) |
| Mar 2021 | - | -$777.50 K(-9.6%) | -$3.21 M(-5.9%) |
| Dec 2020 | -$3.42 M(-26.7%) | -$860.00 K(+32.8%) | -$3.41 M(-7.2%) |
| Sept 2020 | - | -$647.70 K(-30.3%) | -$3.68 M(+0.2%) |
| June 2020 | - | -$929.00 K(-5.0%) | -$3.67 M(-5.3%) |
| Mar 2020 | - | -$978.20 K(-12.9%) | -$3.88 M(-16.8%) |
| Dec 2019 | -$4.66 M(-26.5%) | - | - |
| Dec 2019 | - | -$1.12 M(+75.4%) | -$4.66 M(-14.2%) |
| Sept 2019 | - | -$640.50 K(-43.6%) | -$5.43 M(-18.5%) |
| June 2019 | - | -$1.14 M(-35.5%) | -$6.67 M(-3.1%) |
| Mar 2019 | - | -$1.76 M(-7.0%) | -$6.88 M(+8.4%) |
| Dec 2018 | -$6.35 M(+40.0%) | - | - |
| Dec 2018 | - | -$1.89 M(+1.2%) | -$6.35 M(+12.1%) |
| Sept 2018 | - | -$1.87 M(+38.7%) | -$5.66 M(+11.6%) |
| June 2018 | - | -$1.35 M(+9.9%) | -$5.07 M(+5.9%) |
| Mar 2018 | - | -$1.23 M(+1.7%) | -$4.79 M(+5.7%) |
| Dec 2017 | -$4.53 M(+139.5%) | -$1.21 M(-5.9%) | -$4.53 M(+17.2%) |
| Sept 2017 | - | -$1.28 M(+20.1%) | -$3.87 M(+26.4%) |
| June 2017 | - | -$1.07 M(+10.3%) | -$3.06 M(+23.2%) |
| Mar 2017 | - | -$970.00 K(+78.7%) | -$2.48 M(+31.1%) |
| Dec 2016 | -$1.89 M(+66.9%) | -$542.90 K(+14.1%) | -$1.89 M(+13.6%) |
| Sept 2016 | - | -$475.90 K(-3.5%) | -$1.67 M(-11.5%) |
| June 2016 | - | -$493.10 K(+29.6%) | -$1.88 M(+28.5%) |
| Mar 2016 | - | -$380.60 K(+20.1%) | -$1.47 M(+29.2%) |
| Dec 2015 | -$1.13 M | -$317.00 K(-54.2%) | -$1.13 M(+38.8%) |
| Sept 2015 | - | -$692.80 K(+826.2%) | -$816.70 K(+95.3%) |
| June 2015 | - | -$74.80 K(+52.3%) | -$418.10 K(-55.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$49.10 K(-83.3%) | -$934.90 K(-46.6%) |
| Dec 2014 | -$1.18 M(-27.5%) | - | - |
| Sept 2014 | - | -$294.20 K(-50.3%) | -$1.75 M(+9.7%) |
| June 2014 | - | -$591.60 K(-23.7%) | -$1.60 M(-1.9%) |
| Mar 2014 | -$1.63 M(-17.4%) | -$774.90 K(+756.2%) | -$1.63 M(+50.9%) |
| Dec 2013 | - | -$90.50 K(-35.1%) | -$1.08 M(-24.4%) |
| Sept 2013 | - | -$139.40 K(-77.6%) | -$1.43 M(-25.8%) |
| June 2013 | - | -$622.40 K(+175.8%) | -$1.92 M(-2.5%) |
| Mar 2013 | -$1.97 M(-15.6%) | -$225.70 K(-48.6%) | -$1.97 M(-16.7%) |
| Dec 2012 | - | -$438.70 K(-30.9%) | -$2.37 M(-6.7%) |
| Sept 2012 | - | -$635.20 K(-5.4%) | -$2.54 M(+10.8%) |
| June 2012 | - | -$671.20 K(+8.1%) | -$2.29 M(-2.0%) |
| Mar 2012 | -$2.34 M(+1.1%) | -$620.90 K(+1.8%) | -$2.34 M(-7.0%) |
| Dec 2011 | - | -$609.80 K(+57.4%) | -$2.51 M(-1.1%) |
| Sept 2011 | - | -$387.30 K(-46.0%) | -$2.54 M(+22.0%) |
| June 2011 | - | -$717.80 K(-10.0%) | -$2.08 M(-9.8%) |
| Mar 2011 | -$2.31 M(-41.6%) | -$797.20 K(+24.8%) | -$2.31 M(-16.1%) |
| Dec 2010 | - | -$639.00 K(-1009.0%) | -$2.76 M(-9.0%) |
| Sept 2010 | - | $70.30 K(-107.4%) | -$3.03 M(-27.2%) |
| June 2010 | - | -$945.30 K(-23.9%) | -$4.16 M(+5.1%) |
| Mar 2010 | -$3.96 M(+21.0%) | -$1.24 M(+36.2%) | -$3.96 M(+28.2%) |
| Dec 2009 | - | -$912.00 K(-14.0%) | -$3.09 M(+23.2%) |
| Sept 2009 | - | -$1.06 M(+43.0%) | -$2.51 M(+6.2%) |
| June 2009 | - | -$741.90 K(+99.3%) | -$2.36 M(-27.9%) |
| Mar 2009 | -$3.27 M(-39.5%) | -$372.20 K(+12.4%) | -$3.27 M(-18.8%) |
| Dec 2008 | - | -$331.00 K(-63.8%) | -$4.03 M(-19.0%) |
| Sept 2008 | - | -$915.00 K(-44.6%) | -$4.97 M(-12.0%) |
| June 2008 | - | -$1.65 M(+46.6%) | -$5.65 M(+4.6%) |
| Mar 2008 | -$5.40 M(+83.6%) | -$1.13 M(-11.8%) | -$5.40 M(+0.3%) |
| Dec 2007 | - | -$1.28 M(-19.9%) | -$5.39 M(+15.4%) |
| Sept 2007 | - | -$1.60 M(+13.8%) | -$4.67 M(+23.9%) |
| June 2007 | - | -$1.40 M(+26.0%) | -$3.77 M(+28.1%) |
| Mar 2007 | -$2.94 M(+122.3%) | -$1.11 M(+98.6%) | -$2.94 M(+30.5%) |
| Dec 2006 | - | -$560.40 K(-19.4%) | -$2.26 M(+5.8%) |
| Sept 2006 | - | -$695.50 K(+21.1%) | -$2.13 M(+22.0%) |
| June 2006 | - | -$574.40 K(+35.1%) | -$1.75 M(+31.9%) |
| Mar 2006 | -$1.32 M | -$425.20 K(-2.6%) | -$1.32 M(+47.3%) |
| Dec 2005 | - | -$436.60 K(+40.5%) | -$899.00 K(+94.4%) |
| Sept 2005 | - | -$310.80 K(+105.0%) | -$462.40 K(+205.0%) |
| June 2005 | - | -$151.60 K | -$151.60 K |
FAQ
- What is ProMIS Neurosciences annual cash flow from operations?
- What is the all time high annual CFO for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual CFO year-on-year change?
- What is ProMIS Neurosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly CFO year-on-year change?
- What is ProMIS Neurosciences TTM cash flow from operations?
- What is the all time high TTM CFO for ProMIS Neurosciences?
- What is ProMIS Neurosciences TTM CFO year-on-year change?
What is ProMIS Neurosciences annual cash flow from operations?
The current annual CFO of PMN is -$10.84 M
What is the all time high annual CFO for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual cash flow from operations is -$1.13 M
What is ProMIS Neurosciences annual CFO year-on-year change?
Over the past year, PMN annual cash flow from operations has changed by +$6.19 M (+36.34%)
What is ProMIS Neurosciences quarterly cash flow from operations?
The current quarterly CFO of PMN is -$6.67 M
What is the all time high quarterly CFO for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly cash flow from operations is $70.30 K
What is ProMIS Neurosciences quarterly CFO year-on-year change?
Over the past year, PMN quarterly cash flow from operations has changed by -$4.29 M (-180.71%)
What is ProMIS Neurosciences TTM cash flow from operations?
The current TTM CFO of PMN is -$22.23 M
What is the all time high TTM CFO for ProMIS Neurosciences?
ProMIS Neurosciences all-time high TTM cash flow from operations is -$151.60 K
What is ProMIS Neurosciences TTM CFO year-on-year change?
Over the past year, PMN TTM cash flow from operations has changed by -$10.59 M (-90.95%)